Nicotine regulation watch: 2–12 October 2026

Dates and scope below are as published by the authorities named. Statuses change quickly, and this summary is not legal advice.

United Kingdom — new sales rules start 29 October 2026

Core sales provisions of the Tobacco and Vapes Act 2026, which received Royal Assent on 29 April 2026, take effect on 29 October 2026. From that date the age of sale for all vaping and non-medicinal nicotine products is 18 across the UK, and proxy purchasing, consumer-facing vending machines, free promotional distribution and substantial promotional discounts are restricted¹. Department of Health and Social Care guidance lists nicotine pouches, dissolvable nicotine strips, nicotine pearls and synthetic nicotine within scope; licensed nicotine-replacement medicines and medical devices are excluded². No statutory nicotine-strength cap for pouches has been set, though the Act allows ministers to introduce one.

What it means for manufacturers: UK customers need age-verification, promotion and vending compliance in place before 29 October, and this is the first major market whose retail text names synthetic nicotine explicitly.

European Union — eight member states set out a joint position

On 6 October 2026 the health ministries of the Netherlands, Belgium, Finland, France, Hungary, Latvia, Slovenia and Spain wrote jointly to Health Commissioner Olivér Várhelyi³. They asked for a halt on new consumer products containing "nicotine or nicotine-like substances" outside the current directive, broad flavour restrictions across authorised categories, plain packaging, maximum nicotine levels, standardised products, tighter advertising and distance-selling rules, and national discretion to ban nicotine pouches and single-use e-cigarettes⁴. The letter is a negotiating position, not legislation. A comparable letter in March 2025 carried twelve signatories. The Commission is expected to publish its directive revision proposal by the end of 2026⁵.

What it means for manufacturers: the proposed scope covers nicotine regardless of origin, so EU product pipelines should be planned against the directive proposal rather than today's rules.

Australia — 6-methylnicotine prohibited from 1 October 2026

Australia's Therapeutic Goods Administration published a final scheduling decision on 25 September 2026 placing 6-methylnicotine, a nicotine analogue, in Schedule 9 of the Poisons Standard as a prohibited substance, effective 1 October 2026⁶. The original proposal had been Schedule 7; the delegate adopted the stricter classification and applied it immediately, citing acute toxicity, dependence risk and use in unapproved consumer products including e-liquids and oral pouches. The decision was taken through the Advisory Committee on Medicines Scheduling process, which received 163 consultation responses. The notice states that no lawful Australian products are affected⁷.

What it means for manufacturers: formulations relying on nicotine analogues rather than nicotine are now unlawful in Australia, and regulators are increasingly drafting rules around the substance class rather than the plant of origin.

Spain — pouch nicotine limit still in draft

Spain's draft royal decree amending Royal Decree 579/2017 remains unadopted. The version notified to the European Commission in January 2025 set a limit of 0.99 mg of nicotine per pouch in Article 52(1)(a); several member states filed detailed opinions, extending the standstill period⁸. Trade press reports that a revised draft raises the limit to 4 mg per pouch and that the text has gone to the Council of State for review, while retaining a prohibition on non-tobacco flavours⁹. The 4 mg figure has not been confirmed in a published official text, so the 0.99 mg notification remains the only officially documented figure.

What it means for manufacturers: Spanish product specifications cannot be fixed yet, and planning should treat the concentration limit as open until an official text is published.

United States — state-level market access tightens

Two state measures took effect or begin enforcement this month. Virginia's retail tobacco permit requirement took effect on 1 October 2026, requiring businesses selling covered tobacco and nicotine products to hold a permit from the Virginia Alcoholic Beverage Control Authority; more than 3,000 businesses applied in September, and qualifying pending applicants may operate under a letter of authorisation until 1 December¹⁰. In Pennsylvania, from 19 October 2026 nicotine-containing e-cigarettes not listed on the state ENDS directory may no longer be sold at retail, with 22 manufacturer certifications still under review¹¹.

What it means for manufacturers: US market access increasingly depends on state directory listings and retail permits in addition to federal premarket requirements.

About ESSENZ

ESSENZ supplies synthetic (S)-nicotine to manufacturers, business to business, with full documentation for each batch. For samples, a certificate of analysis or a quote, write to contact@essenz.bio.